Quetiapine Fumarate Tablet
Product Images NDC 50268-635
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 50268-635). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label 5026863115 Quetiapine 50mg 2016
This is a description of a medication called Quetiapine Fumarate Tablets, which is only available by prescription. The medication is available in two options: a bottle of 50 tablets (with a dose of 5 tablets each time) or a bottle of 30 tablets (with a dose of 1 tablet each time) that contain 50mg of the medication. There is also some blurred or unreadable text visible.*
Label 5026863215 Quetiapine 100mg 2016
Label 5026863315 Quetiapine 200mg 2016
Description: Quetiapine Fumarate Tablets are a prescription medication with a strength of 20mg. It comes in a pack of 50 tablets and has a recommended dose of 510 units. The text also includes the brand name "Guehupme" and the letters "Rx only" and "R only." The last line of text is not readable and cannot be used for description.*
Label 5026863415 Quetiapine 300mg 2018
This is a description of a medication. The medication is Quetiapine, which comes in tablet form. It is a prescription drug indicated for a specific use. The medication comes in a container that has 50 tablets and is labeled with the National Drug Code (NDC) 50268-634-15 and other information. There is a warning advising the user to keep this medication away from the reach of children. The medication is manufactured by AKAFE.*
Label 5026863515 Quetiapine 400mg 2016
Figure 1 (Quetiapine Fig1)
This appears to be a graph showing the proportion of patients with relapse over time. The X-axis measures time in weeks and the Y-axis represents the percentage of patients experiencing relapse. The data is presented using a Kaplan-Meier curve, specifically for the recurrence of a mood event in Study 7.*
Figure 2 (Quetiapine Fig2)
Structure (Quetiapine Stru)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.